CORRIGAN MARK
Insider CIK 1250661 · ZLCS President & CEO, Director · CLCD Director · TRVN Director · WVE Director · NBRV Director · NBRV Director · NVLN Director · CBST Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WVE Wave Life Sciences, Inc. | A Award deriv | 2026-10-05 | 2026-10-07 | 64,000 | — | $0 | 64,000 | SEC↗ |
| WVE Wave Life Sciences, Inc. | A Award | 2026-10-05 | 2026-10-07 | 10,700 | — | $0 | 39,515 | SEC↗ |
| WVE Wave Life Sciences Ltd. | S Sale | 2025-12-08 | 2025-12-10 | 6,515 | $14.07 | $91.7K | 28,815 | SEC↗ |
| WVE Wave Life Sciences Ltd. | S Sale | 2025-12-08 | 2025-12-10 | 9,600 | $13.09 | $125.7K | 35,330 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2025-08-11 | 2025-08-13 | 76,200 | — | $0 | 76,200 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award | 2025-08-11 | 2025-08-13 | 12,700 | — | $0 | 44,930 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2024-08-12 | 2024-08-14 | 64,460 | — | $0 | 64,460 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award | 2024-08-12 | 2024-08-14 | 32,230 | — | $0 | 32,230 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2024-06-13 | 2024-06-14 | 13,700 | — | $0 | 13,700 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2023-08-07 | 2023-08-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2023-07-18 | 2023-07-20 | 34,250 | — | $0 | 34,250 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2022-08-15 | 2022-08-17 | 21,000 | — | $0 | 21,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2022-08-02 | 2022-08-04 | 10,297 | $0.19 | $2.0K | 7,203 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2021-08-16 | 2021-08-18 | 21,000 | — | $0 | 21,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2021-07-28 | 2021-07-30 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2021-07-28 | 2021-07-30 | 17,500 | — | $0 | 17,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2021-06-02 | 2021-06-04 | 10,500 | — | $0 | 10,500 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2020-08-18 | 2020-08-20 | 10,500 | — | $0 | 10,500 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2019-09-04 | 2019-09-06 | 21,000 | — | $0 | 21,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-07-31 | 2019-08-01 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2018-08-09 | 2018-08-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-05-02 | 2018-05-04 | 29,000 | — | $0 | 29,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2017-09-15 | 2017-09-19 | 10,100 | — | $0 | 10,100 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 10,100 | — | $0 | 10,100 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 20,200 | — | $0 | 20,200 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2017-03-30 | 2017-04-11 | 9,600 | — | $0 | 9,600 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2017-03-30 | 2017-03-31 | 9,600 | — | $0 | 9,600 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | D To issuer deriv | 2017-03-01 | 2017-03-01 | 8,897 | $40.26 | $358.2K | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | D To issuer deriv | 2017-03-01 | 2017-03-01 | 8,114 | $42.71 | $346.5K | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | A Award deriv | 2016-05-10 | 2016-05-12 | 8,897 | — | $0 | 8,897 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | A Award deriv | 2015-10-27 | 2015-10-29 | 8,114 | — | $0 | 8,114 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | A Award deriv | 2015-06-05 | 2015-06-08 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 9,472 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 9,367 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 8,370 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 6,202 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 1,687 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 16,519 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2015-01-21 | 2015-01-21 | 7,501 | $102.00 | $765.1K | 0 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | F Tax w/h | 2014-07-15 | 2014-07-17 | 14,597 | $11.80 | $172.2K | 21,859 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-06-03 | 2014-06-05 | 1,104 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-06-03 | 2014-06-05 | 6,202 | — | $0 | 6,202 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-06-03 | 2014-06-05 | 1,687 | — | $0 | 1,687 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-06-03 | 2014-06-05 | 1,104 | — | $0 | 7,501 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award | 2014-06-03 | 2014-06-05 | 899 | — | $0 | 6,397 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-02-27 | 2014-02-28 | 5,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-02-27 | 2014-02-28 | 5,000 | $80.00 | $400.0K | 5,498 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-02-27 | 2014-02-28 | 5,000 | $18.22 | $91.1K | 10,498 | SEC↗ |
| ZLCS Zalicus Inc. | A Award deriv | 2014-02-10 | 2014-02-12 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ZLCS Zalicus Inc. | A Award | 2014-02-10 | 2014-02-12 | 250,000 | — | $0 | 364,567 | SEC↗ |
| ZLCS Zalicus Inc. | F Tax w/h | 2014-01-15 | 2014-01-17 | 18,079 | $1.66 | $30.0K | 114,567 | SEC↗ |
| ZLCS Zalicus Inc. | F Tax w/h | 2014-01-03 | 2014-01-07 | 8,035 | $1.22 | $9.8K | 132,646 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-06-12 | 2013-06-14 | 1,104 | — | $0 | 1,104 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-06-12 | 2013-06-14 | 8,370 | — | $0 | 8,370 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award | 2013-06-12 | 2013-06-14 | 995 | — | $0 | 5,498 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-06-06 | 2013-06-11 | 1,347 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-06-06 | 2013-06-11 | 1,347 | — | $0 | 4,503 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-24 | 2013-05-29 | 14,000 | — | $0 | 5,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-24 | 2013-05-29 | 14,000 | $54.60 | $764.4K | 3,156 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-24 | 2013-05-29 | 14,000 | $18.22 | $255.1K | 17,156 | SEC↗ |
| ZLCS Zalicus Inc. | S Sale | 2013-01-15 | 2013-01-17 | 112,850 | $0.77 | $86.9K | 844,090 | SEC↗ |
| ZLCS Zalicus Inc. | A Award deriv | 2013-01-03 | 2013-01-07 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ZLCS Zalicus Inc. | A Award | 2013-01-03 | 2013-01-07 | 250,000 | — | $0 | 956,940 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-07-24 | 2012-07-26 | 10,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-07-24 | 2012-07-26 | 10,000 | $41.01 | $410.1K | 3,156 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-07-24 | 2012-07-26 | 10,000 | $17.78 | $177.8K | 13,156 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-06-06 | 2012-06-11 | 9,367 | — | $0 | 9,367 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-06-06 | 2012-06-11 | 1,347 | — | $0 | 1,347 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award | 2012-06-06 | 2012-06-11 | 873 | — | $0 | 3,156 | SEC↗ |
| ZLCS Zalicus Inc. | A Award deriv | 2012-01-25 | 2012-01-27 | 799,226 | — | $0 | 799,226 | SEC↗ |
| ZLCS Zalicus Inc. | A Award deriv | 2012-01-25 | 2012-01-27 | 100,774 | — | $0 | 100,774 | SEC↗ |
| ZLCS Zalicus Inc. | S Sale | 2012-01-17 | 2012-01-19 | 68,105 | $1.14 | $77.6K | 706,940 | SEC↗ |